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Background: Cadmium zinc telluride (CZT) solid-state detectors have been recently introduced in the field of
nuclear medicine in cardiology and breast imaging. The aim of the current study was to evaluate the performance
of the novel detectors (CZT) compared to that of the routine NaI(Tl) in bone scintigraphy. A dual-headed CZT-based
camera dedicated originally to breast imaging has been used, and in view of the limited size of the detectors, the
hands were chosen as the organ for assessment. This is a clinical study.
Methods: Fifty-eight consecutive patients (total 116 hands) referred for bone scan for suspected hand pathology
gave their informed consent to have two acquisitions, using the routine camera and the CZT-based camera. The
latter was divided into full-dose full-acquisition time (FD CZT) and reduced-dose short-acquisition time (RD CZT) on
CZT technology, so three image sets were available for analysis. Data analysis included comparing the detection of
hot lesions and identification of the metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints.
Results: A total of 69 hot lesions were detected on the CZT image sets; of these, 61 were identified as focal sites of
uptake on NaI(Tl) data. On FD CZT data, 385 joints were identified compared to 168 on NaI(Tl) data (p < 0.001). There
was no statistically significant difference in delineation of joints between FD and RD CZT data as the latter identified
383 joints.
Conclusions: Bone scintigraphy using a CZT-based gamma camera is associated with improved lesion detection and
anatomic definition. The superior physical characteristics of this technique raised a potential reduction in administered
dose and/or acquisition time without compromising image quality.
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Gamma cameras are composed of semiconductor
cadmium zinc telluride (CZT) detectors dedicated to
cardiac perfusion studies and to molecular breast im-
aging (MBI). Cardiac CZT-based cameras were found to
offer ultrafast myocardial perfusion imaging with better
spatial resolution and count rate, thus allowing reduc-
tion of injected dose and/or acquisition time potentially
overcoming the problems of motion artifacts and im-
proved patient comfort [1–8]. Dual-headed CZT-based
cameras dedicated to MBI have been shown to be* Correspondence: evensap@tasmc.health.gov.il
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the Creative Commons license, and indicate ifvaluable in detection of small lesions of clinical rele-
vance [9–14]. The latter system has been installed in our
facilities and is being used for detection of breast path-
ology. The detection of small breast lesions encouraged
us to conduct the current study and assess the role of
the CZT-based camera for detection of bone and joint
pathology on 99mTc-methylene diphosphonate (MDP)
bone scintigraphy. In view of the small size of the field
of view, imaging of the hands was chosen as our model.Methods
Patient population
The study cohort consisted of 116 hands of 58 consecu-
tive patients, 30 male and 28 female, age 17–90 years
(mean 42 ± 10), referred for 99mTc-MDP boneis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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scintigraphy included trauma (n = 26), pain (n = 28),
unclear lesions on radiography (n = 2), suspected reflex
sympathetic dystrophy (RSD) (n = 1), and sarcoma (n = 1).
The study was approved by the ethical committee of
the Tel Aviv Sourasky Medical Center.Bone scintigraphy
Two to three hours after the injection of 740 MBq
99mTc-MDP, data acquisition was performed using two
separate systems: a routine gamma camera (Infinia or
Optima, GE Healthcare) with a high-resolution collima-
tor and a CZT-based camera (Discovery NM750b, GE
Healthcare) originally aimed for breast imaging. Using
the routine camera, the hands were placed on one of the
camera heads for 10 min. For acquisition using the
CZT-based camera, the hands were placed on the lower
detector while the upper detector was used to
immobilize the hands without pressure. Acquisition on
the CZT-based camera was in dynamic mode, ten im-
ages of 1 min each. The combined data of all ten images
reflect the full-dose full-acquisition time (full data, FD).
A second set of images combining data of the first 4 min
only (reduced data, RD) were generated reflecting the
images obtained by a short (4 min) acquisition or simu-
lating a reduced (296 MBq) injected dose. Thus, for each
patient, three image sets of the hands were available for
assessment: a set obtained by routine camera, FD, and
RD data (Fig. 1).Data analysis
Images were interpreted by two nuclear medicine ex-
perts (VK, HL) in consensus reading. The three data setsFig. 1 A 74-year-old man with non-specific pain in the skeleton including
detector, and reduced-dose (RD) CZT detector image sets. Note the anatom
the CZT data, either FD or RDwere reviewed at least 2 weeks apart, with the readers
blinded to the patient’s name and clinical data. For as-
sessment of lesion detection, any site of increased uptake
was recorded. Interpretation of increased uptake was
based on comparison with the contralateral bone or with
the adjacent bone if both hands showed abnormality.
The criterion for assessment of image quality was the
ability to visualize the location of the metacarpophalan-
geal (MCP), proximal interphalangeal (PIP), and distal
interphalangeal (DIP) joints. Experts also commented on
the ability to identify the joint space, i.e., to visualize the
cold area representing the joint space separating the
proximal and distal bones. On the CZT data of Fig. 2,
for instance, the joint space of the MCP joint of the
third finger is clearly seen while the location of the DIP
joint of this finger can be identified but the joint space
of this joint is not visualized. This figure also illustrates
the ability to determine on the CZT data whether abnor-
mality is present in the bone on both sides or only at
one side of the joint space.
The ability to determine the joints’ location on the data
sets was compared using the McNemar test with p < 0.05
considered statistically significant.
Results
Sixty-nine hot lesions were identified on CZT data
whereas only 61 focal sites of increased uptake were
recorded on NaI(Tl) images (no statistically significant
difference) (Figs. 3 and 4).
Table 1 summarizes the visualization of the MCP,
PIP, and DIP joints by each of the three image sets.
Of the 1624 joints present in the 116 evaluated
hands, locations of 168 joints were identified using
routine detectors compared to 385 joints when usingthe hands. From left to right: routine NaI(Tl) camera, full-dose (FD) CZT
ic details of the bones (including the sesamoid bones) and joints on
Fig. 2 A 72-year-old female with non-specific pain in the hands. Note on the CZT data the detection of a joint space of the third metacarpopha-
langeal joint. Increased uptake is seen only at the bone distal to the joint space (arrow)
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95 % CI 0.145–0.186). No difference was found be-
tween FD and RD images as the latter identified 383
joints. Figures 3 and 4 demonstrate the better detec-
tion of the joints on the CZT data, identifying also
whether increased uptake is present in the bone on
both sides or only at one side of the articulation.
Discussion
Novel gamma cameras with CZT detectors have been
recently introduced in the routine of nuclearFig. 3 A 25-year-old female post left hand trauma. Bone scintigraphy acqu
increased uptake identified at the distal radius and distal carpal bone, focalmedicine, and currently, there are systems dedicated to
molecular breast imaging (MBI) and cardiac perfusion im-
aging. The novel geometric design and new detector ma-
terial combined with new reconstruction algorithms have
been shown in the literature to improve the diagnostic
performance of gamma cameras in cardiac perfusion stud-
ies and scintimammography with superior image quality,
shorter acquisition times, and reduced radiation exposure
[1–14].
Bone scintigraphy is the most common procedure in
nuclear medicine departments that plays an importantisition took place while the hand was in a cast. In addition to the focal
uptake is identified in the lunate bone only on the CZT data (arrow)
Fig. 4 A 71-year-old man with rheumatoid arthritis. On both image data, multiple joints appear to be associated with increased uptake. On the
CZT data, uptake is located on both sides of the joint space (arrow) and the increased uptake at the metacarpophalangeal region of the index finger
appears to be a sesamoid bone (arrowhead)
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ing trauma, joint disease, infection, inflammation, and
neoplastic conditions. The role of CZT detectors for
bone scintigraphy has not been fully appreciated. As the
CZT camera available in our facility is that composed of
a 20 × 20 cm2 detection area tailored from breast im-
aging, we chose a small organ of interest, the hands, to
explore the potential benefit of CZT detectors in bone
scintigraphy. Bone scintigraphy is a common procedure
for assessment of bone and joint pathology in the hand
allowing the detection of posttraumatic changes, infec-
tion, inflammatory or degenerative changes, avascular
necrosis, reflex sympathetic dystrophy, and neoplastic
processes. Bone scintigraphy of the peripheral skeleton
mainly of the small bones and joints of the hands bur-
dens a potential suboptimal spatial resolution and poor
anatomical definition often requiring a longer acquisi-
tion time, zoomed acquisition, and even change of colli-
mators. Image quality may be even more deteriorated inTable 1 Visualization of joints on three image sets: using the
routine NaI(Tl) camera, using full-dose full-time acquisition with
CZT detectors (FD CZT), and using reduced-dose reduced-time
acquisition with CZT detectors (RD CZT)
Image set Total number of lesions MCP PIP DIP
Standard camera 168 116 47 5
FD CZT 385 219 137 29
RD CZT 383 219 137 27
MCP metacarpophalangeal joint, PIP proximal interphalangeal joint, DIP distal
interphalangeal jointpatients with poor blood perfusion secondary to cardio-
vascular disease or peripheral vascular disease, who are
overweight, or with renal and metabolic diseases result-
ing in a decreased tracer dose in the extremities. In chil-
dren, the bones and joints composing the hands are of
particular small size and there should be an ongoing ef-
fort to reduce administered dose and radiation exposure.
Evaluation of arthritis is an ongoing imaging challenge.
Scintigraphy using 99mTc-MDP, labeled immunoglobulin
G (IgG) gamma imaging, and 18F-FDG PET are used for
joint imaging [15–20]. Improved image quality and
visualization of the hand joints was achieved by using a
positron emission mammography (PEM) scanner
(arthro-PEM) [21]. The detection of active inflammation
using non-specific tracers is primarily based on non-
specific mechanisms such as hyperemia and increased
vascular permeability. Recently, specific radiolabeled
mAb including anti-CD20 and anti-TNF-α have been in-
troduced for imaging of chronic inflammatory auto-
immune joint diseases such as rheumatoid arthritis. In
addition to evaluation of disease extent and severity,
findings of immunoscintigraphy may assist in selection
of patients that could benefit from immunotherapy and
for monitoring response to therapy, maintaining the ap-
proach of personalized medicine [22–26]. The results of
our study indicate that image quality reflected by
visualization of joints is significantly improved with the
CZT detectors compared to imaging using the routine
NaI(Tl)-based camera, occasionally allowing to define
whether the scintigraphic abnormality is one sided or
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raise a potential improved performance of immunoscin-
tigraphy of the joints using a CZT-based device. How-
ever, at present, the commercially available CZT systems
are organ specific and/or small while imaging of joint
diseases warrants imaging of larger joints and a whole-
body approach.
In the current study, we did not find a significant dif-
ference neither in lesion detection nor in image quality
between full-dose data and data that simulated reduced
acquisition time or reduced injected dose. This is a
major potential benefit of CZT detectors in the clinical
practice of nuclear medicine.
There are several limitations to the study. First is the
inherent lack of a gold standard for the final diagnosis of
the abnormal scintigraphic findings. The other is the
variable indications of bone scan of the hands and there-
fore the heterogeneous study cohort. This is however a
pilot study, and its results encourage further evaluation
of the role of CZT technology in specific indications of
bone scan as well as scintigraphy using other tracers.
Conclusions
Bone scintigraphy with the novel CZT detectors is asso-
ciated with improved image quality. Radiation dose and/
or acquisition time can be considerably reduced without
compromising lesion detection or image quality using
this technology.
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